ADL Bionatur Solutions - New contract to serve Asia-Pacific API market
ADL Bionatur Solutions (ADL-BS) announced on 7 August 2019 that it entered into a strategic alliance with an undisclosed new customer in Japan to produce sterile active pharmaceutical ingredients (APIs). The customer is a producer of pharmaceuticals, agricultural chemicals and veterinary drugs, and the revenues associated with the contract represent €13m over the next five years.ADL Bionatur Solutions SA Formerly known as Bioorganic Research and Services SA. ADL BIONATUR SOLUTIONS SA (Bionatur), formerly known as Bioorganic Research and Services SA, is a Spain-based company engaged in the management and advice in the development of organic chemical processes carried out by third party entities. Among the chemical projects, the Company comprises the examination and interpretation of samples from waste treatment works, valuation of biological activities and retrosynthetic analysis. The Company's subsidiaries are BBD BioPhenix SL, a San Sebastian-based biotechnology company and Zera Intein Protein Solutions SL.
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.